Stocks to Buy

Identifying winning stocks requires more than scanning headlines. InvestorPlace analysts focus on long-term themes, market timing, and structural shifts shaping where capital is flowing next, highlighting stocks positioned to benefit from those trends.

5 Stocks With Superb Sales Growth — HOFT HBM ZGNX BECN XPLR

By Portfolio Grader
This week, these five stocks have the best ratings in Sales Growth, one of the eight Fundamental Categories on Portfolio Grader.

7 Stocks to Buy in the Healthcare Sweet Spot

By Louis Navellier, Editor, Growth Investor
These are solid companies that are riding a long-term global trend.

9 Best Cheap Stocks to Buy Under $10

By Jeff Reeves
Don't bet the farm on any of these cheap stocks, but if you're looking for a little outperformance, they can do some heavy lifting.

Nvidia Corporation: NVDA Stock Should Be in Your Portfolio for THIS Reason

By Louis Navellier, Editor, Growth Investor
This graphics card maker is entering its era in the sun with a number of catalysts, including virtual and augmented reality.

4 Chemicals Stocks to Buy Now

By Portfolio Grader
This week, 4 Chemicals stocks are improving their overall rating on Portfolio Grader. Each of these rates an "A" ("strong buy") or "B" overall ("buy").

5 Oil Gas & Consumable Fuels Stocks to Buy Now

By Portfolio Grader
This week, 5 Oil Gas & Consumable Fuels stocks are improving their overall rating on Portfolio Grader. Each of these rates an "A" ("strong buy") or "B" overall ("buy").

3 Oversold REITs Yielding 6% or More (APLE, BRG, SBRA)

By
Real estate investment trusts, or REITs, have been on a tear, and these 3 are solid plays for your portfolio

5 Stocks With Strong Earnings Revisions — KLIC MT NMIH SWC RFP

By Portfolio Grader
This week, these five stocks have the best ratings in Earnings Revisions, one of the eight Fundamental Categories on Portfolio Grader.

Dicks Sporting Goods Inc (DKS): More Analyst Love!

By Dan Burrows, InvestorPlace Feature Writer
DKS stock analysts say fears of disruption from Dicks Sporting Goods' winning bid for Sports Authority are overblown.

10 Stocks With More Upside Than Apple Inc. (AAPL)

By Brian Nichols, InvestorPlace Contributor
While Apple Inc (AAPL) should still post solid growth, these ten take a bite out of Apple's upside with huge potential of their own.

JPMorgan Chase & Co.: JPM Stock Set for a Strong Second Half

By Dan Burrows, InvestorPlace Feature Writer
JPMorgan Chase (JPM) kicked off bank earnings season with a blast, with better-than-expected earnings driven by loan growth and cost cuts.

Apple Inc. (AAPL) Stock Is Due for a Rally

By Marie Brodbeck, InvestorPlace Contributor
Apple stock is a buy at under $100 per share. AAPL has a lot of upside potential for investors that are willing to wait out a turbulent 2016.

4 Software Stocks to Buy Now

By Portfolio Grader
The grades of 4 Software stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating.

4 Internet Software & Services Stocks to Buy Now

By Portfolio Grader
This week, 4 Internet Software & Services stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").

4 Auto Components Stocks to Buy Now

By Portfolio Grader
This week, 4 Auto Components stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").

5 Stocks With Superb Surprise — FCN EEQ PKX TIS ROCK

By Portfolio Grader
This week, these five stocks have the best ratings in Surprise, one of the eight Fundamental Categories on Portfolio Grader.

3 Gold Stocks Running Hot on Economic Fears

By Josh Enomoto, InvestorPlace Contributor
Gold stocks and gold miners are back with a vengeance, with rising fear in the markets ensuring this isn't a one-off move.

The Bias in Oil Prices Remains to the Upside (USO DWTI UWTI)

By Dan Burrows, InvestorPlace Feature Writer
Contradictory data makes the oil trade a dangerous game, but the outlook remains slightly more bullish than bearish.

Valeant Pharmaceuticals Intl Inc (VRX) Plunges After Losing Sequoia Fund

By John Kilhefner, Senior Managing Editor, Lango Franchise
Sequoia Fund sold out its Valeant Pharmaceuticals (VRX) stake, but investors initial saw opportunity where Sequoia did not.
Load More Articles